The Cancer Science Institute Singapore (CSI Singapore) at the National University of Singapore (NUS) adopts a multifaceted and coordinated approach to cancer research, extending from basic cancer studies all the way to experimental therapeutics. The vision is to make the CSI Singapore one of the top cancer research centres in the world, with highly interrelated programmes leading to an integrated approach to better understand and treat cancer.
The CSI Singapore is led by Professor Daniel Tenen from Harvard Medical School.
Professor Tenen is a leader in the field of transcriptional regulation, hematopoiesis and cancer.
|
